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Inactivating the type I keratin 17 gene (mK17) causes severe but reversible hair loss in a strain-dependent fashion in
mouse (McGowan et al, Genes Dev. 16:1412, 2002). Missense mutations in human K17 give rise to two dominantly
inherited disorders apparented to ectodermal dysplasias, pachyonychia congenita (PC), and steatocystoma
multiplex (SM). In contrast to the null phenotype in mouse, marked lesions are seen in the nail and nail bed and
sebaceous glands of PC and SM patients, respectively. In an effort to understand the lack of nail involvement in
mK17 null mice, we discovered that the gene located immediately 50 upstream frommK17 is functional and encodes
a type I keratin protein highly analogous to mK17. mRNA and protein localization studies show that the expression
of this novel gene is highly restricted and most prevalent in the nail bed and matrix, leading to its designation as
mK17n (n stands for nail). Weak expression of mK17n also occurs in vibrissae follicles, in ﬁliform and fungiform
papillae of oral mucosa. These ﬁndings have direct implications for the mK17 null phenotype. Depending on the
existence of a human ortholog or a functional equivalent, our ﬁndings may also provide a molecular explanation for
several unusual aspects of hK17-based diseases.
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Type I and type II keratin proteins are the most abundant
proteins of epithelial cells, in which they heteropolymerize
to form cytoplasmic intermediate filaments (IF). They are
encoded by a large family of conserved genes, with  50
functional loci known so far in mammalian genomes (Hesse
et al, 2001). The functional type I (K9–K23; Ha1–Ha8) and
type II keratin genes (K1–K8; Hb1–Hb6) are each clustered
on distinct chromosomes in the human and mouse gen-
omes. The pairwise and differentiation-related regulation of
most type I and type II keratin genes provides a unique
handle to track differentiation within epithelial tissue (Fuchs,
1995). A family-wide, crucial function of keratin filaments is to
endow epithelial cells with the ability to withstand mechan-
ical and other forms of stress. Accordingly, mutations in
keratin genes are responsible for a number of genetically
based fragility disorders involving specific cell types(s) in skin
and other epithelia (Fuchs and Cleveland, 1998; Irvine and
McLean, 1999; Coulombe and Omary, 2002). Additional
functions for keratin proteins are emerging, although these
are cell-type and context-dependent in nature (Coulombe
and Omary, 2002). Other than this knowledge, it has been
proven difficult to pinpoint the significance of differential
regulation within the keratin gene family. As recently
suggested (Wong and Coulombe, 2003), the differential
regulation of keratin genes may foster the elaboration of
keratin IF networks with distinct properties that, in turn,
enable epithelial cells to achieve an optimal compromise
between the pliability and resilience demanded upon them.
Among type I keratin genes, K17 stands out in multiple
ways. In mouse embryonic skin, it is first expressed
in ectodermal cells committing to a non-epidermal cell
fate (i.e., all appendages and periderm) in response to
mesenchymal induction (McGowan and Coulombe, 1998a).
Of equal interest, mK17 also becomes wound-inducible
prior to the onset of terminal differentiation within develop-
ing skin epithelia, and is expressed in periderm cells
recruited to form temporary epithelial fusions in digits,
eyelids, and the ear (Mazzalupo et al, 2001, 2003).
Concomitant with skin maturation, mK17 expression be-
comes restricted to specific cell layers and compartments
within all major types of epithelial appendages (Troyanovsky
et al, 1992; Panteleyev et al, 1997; McGowan and
Coulombe, 1998a). Both hK17 and mK17 can be coregu-
lated with distinct type II keratin genes (e.g., K5, K6a, K6b,
K6hf) in mature epithelial settings (Smith et al, 1998;
McGowan and Coulombe, 1998a, 2000; De Berker et al,
2000; Wang et al, 2003). In addition to its constitutive
expression in epithelial appendages, K17 expression is
induced in mature interfollicular epidermis subjected to
various types of acute challenges (e.g., injury, UV exposure,
inflammation) or during diseases (e.g., psoriasis, basal cell
carcinoma) (McGowan and Coulombe, 1998b; Freedberg
et al, 2001). Finally, mutations affecting a particular segment
of hK17’s coding sequence can cause two distinct disorders
of the skin, each related to ectodermal dysplasias (Irvine
and McLean, 1999). In type 2 pachyonychia congenita (PC),
lesions show a predilection for the nail, although other
epithelial appendages are usually affected. In steatocystoma
multiplex (SM), sebaceous glands expand dramatically to formAbbreviation: PC, pachyonychia congenita
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large subepidermal cysts. The molecular basis of this clinical
heterogeneity is not understood (Irvine and McLean, 1999),
although the epithelial tissues affected in these disorders do
express the K17 gene (McLean et al, 1995; McGowan and
Coulombe, 1998a, 2000; De Berker et al, 2000).
We recently introduced a null mutation in mK17 to define
the functional importance of its protein product in mouse
(McGowan et al, 2002). mK17 null mice fail to develop a
dense fur coverage over much of their body during the first
week post-birth, owing to a combination of hair shaft
fragility and untimely apoptosis of hair-producing tissue.
Susceptibility of mice towards this phenotype is remarkably
strain-dependent. Irrespective of strain background, how-
ever, there is a significant normalization occurring con-
comitant with the first postnatal anagen phase of the hair
cycle at  3 wk post-birth. Normalization correlates with
the upregulation of mK16, a type I keratin related to mK17
(McGowan et al, 2002). Whereas a nail phenotype was
expected as well based upon the role of hK17 mutations in
producing type 2 PC (McLean et al, 1995; Irvine and
McLean, 1999), it is completely missing in mK17 null mice.
Here we report on the existence of a K17-like gene that is
preferentially expressed in the mouse nail bed and matrix.
The mK17n gene (n stands for nail) is located immediately 50
from the known K17 gene, and is poised to compensate for
the absence of K17 protein in mK17 null nail tissue. Whether
the corresponding locus in the human genome, to which
mK17n is highly homologous, is functional remains unclear.
Should it be the case, this would have direct implications for
a number of oddities characterizing K17 mutation-based
diseases, including phenotypic heterogeneity and the
unusual restriction of mutations to a narrow segment of
the K17 coding sequence. Our findings also point to a
specific candidate gene for the rare instances of PC where
alterations are restricted to the nail.
Results and Discussion
Three lines of evidence led us to postulate the existence of
a K17-like gene that would be expressed in the nail bed
epithelium. First, mK17 null mice do not exhibit alterations in
the nail (McGowan et al, 2002). mK6a/mK6b null mice also
fail to show anomalies in the nail (Wong et al, 2000; Wojcik
et al, 2001), and subsequent studies revealed that in this
instance a related keratin gene, mK6hf, is expressed in the
nail bed (Wojcik et al, 2001; Wang et al, 2003). Yet, neither
K16 nor K14 (to which K17 is related) change significantly in
protein extracts prepared from mK17 null nails (McGowan
et al, 2002). Second, we find that there is residual
immunoreactivity when staining for the K17 antigen in
mK17 null nail tissue sections, but not in any other tissue
known to express mK17 (see below). Third, while screening
from a mouse genomic DNA library a few years ago, we
came across phage clones containing a type I keratin gene
located  2 kb upstream from the functional mK17 gene.
This locus was predicted to encode a polypeptide highly
related to K17. We did not pursue this finding then (see
McGowan and Coulombe, 1998a) in part because the
corresponding gene in the human type I keratin gene cluster
had been deemed inactive (Troyanovsky et al, 1992). Re-
evaluation of our data revealed that eight of the last 11
amino acids in the peptide used to generate the polyclonal
anti-K17 antiserum are conserved in the hypothetical
product of the upstream K17-like gene. This raised the
possibility that the product of this hypothetical gene could
account for the residual K17 immunoreactivity seen in mK17
null mice. Altogether, these observations encouraged us to
complete the characterization of this novel mouse keratin
gene and in particular determine whether it is expressed in
nail tissue.
Cloning and partial characterization of the K17n gene
Completion of our previous efforts made towards the
cloning and characterization of mK17 (McGowan and
Coulombe, 1998a) and mK16 (Bernot et al, 2002) gave rise
to genomic contig of 25,772 nucleotides. The postulated
mK17n locus is located immediately 50 upstream of mK17
and is entirely contained within that contig (Fig 1A). We
exploited the notion that (i) all mammalian type I keratin
genes characterized so far display an identical structure,
and (ii) the existence of a high degree of homology between
mK17n and mK17, to identify a candidate ATG translation
start codon and a polyA signal (AAUAA) within the 30 non-
coding in the mK17n sequence. We designed forward and
reverse oligonucleotide primers predicted to be specific for
the mK17n mRNA in an RT-PCR assay. Using total RNA
from mK17 null tissues, these primers led to the amplifi-
cation of an  1.5 kb product that was more abundant
in digit samples compared with other body sites (Fig 1B).
In contrast to dig, however, lower amounts of mK17n
amplicons were detected in tongue and vibrissae RNA
samples from mK17 null relative to wild-type mice.
Comparison of the nucleotide sequence of the amplicon
(deposited in GenBank under Acc. No. AY459292) with the
genomic contig mentioned above revealed a clear pre-
cursor–product relationship, and enabled us to ascertain
the position of the intron–exon boundaries (Lewin, 1994). In
addition, our sequence data were further validated by
comparison with databanks. At a genomic DNA level, for
instance, the contig that we cloned and characterized is
entirely contained within Genbank entry AL590873. This
entry corresponds to a BAC clone (RP23-217I3; 182,009 bp
long) originating from the region of mouse chromosome 11
that contains a large cluster of functional type I keratin
genes. At the cDNA level, the sequence of our cDNA clone
matches that of Genbank entry AK019133, which cor-
responds to an expressed sequence tag mapped to the
exact same region of the mouse type I keratin locus as
viewed at a publicly available mouse genome database
(Ensembl sequencing consortium; see Methods).
The mK17n gene is  6.97 kb long (from translation start
to polyA signal) and consists of eight protein-coding exons
separated by seven introns (Fig 1C). It is located at the
telomeric boundary of the cluster of type I keratin genes on
mouse chromosome 11 (Fig 1A). This contiguity, along with
the identical transcriptional orientation and sequence
homology, argues strongly in favor of a common ancestral
origin for mK17 and mK17n (Lewin, 1994). Inspection of the
50 upstream sequence in the genomic clone containing
mK17n reveals the presence of a ‘‘TATA’’ motif located 60 bp
upstream of a potential ATG translation start site matching
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the consensus sequence defined by Kozak (Kozak, 1987).
The last exon (no. 8) encodes for the last 32 amino acids
within the C-terminal tail domain and the entire 30 non-
coding sequence, including a polyA signal located 161 bp
downstream from the in-frame translation stop codon. The
protein product of mK17n is predicted to consist of 452
amino acids, with calculated mass and pI of 50,147 Da, and
4.9, respectively. It shows 67% identity with mK17 (Fig 1D),
to which it shows the highest homology among mouse
keratin sequences. When partitioned into the individual
head, central a-helical rod, and tail domains, the two
proteins show 16%, 82%, and 63% identity, respectively.
Mouse K17n: MDSTTSVRQFSTSGSVKGLCAPGMGFSRMSSVRVGGACRAPSLLGGGSCGNMSVTSSRFSAGLGG
            *   *##***##* *#**    * * ** *       **    ** ***      *   **   
Mouse K17:   M--ATTIRQFTSSSSIKGSSGLGGGSSRTS-------CRLSGSLGAGSC-RLGSASGLGSALGSN
GYGGGYTCSLGGGFGSSFGVSDALLGGSEKETMQNLNDRLATYLDRVRALEEANADLEVKIREWYKKQGPGPARDYSP
 *   *#   * * *  **  * ** * ** **********#***#******** #******#** ** ******** 
SYSSCYSFGTGSGYGGNFGGVDGLLAGGEKATMQNLNDRLASYLDKVRALEEANTELEVKIRDWYQKQAPGPARDYSA
YFKTIEDLRNKILAATIDNASIVLQIDNARLAADDFRTKYETELNLRMSVEADINGLRRVLDELTLARADLEMQIESL
*  *****#**** **#*****#**************** ***  ******************************* *
YYHTIEDLKNKILVATVDNASILLQIDNARLAADDFRTKFETEQALRMSVEADINGLRRVLDELTLARADLEMQIENL
KEELAYLRKSHEEEMNALRGQVGGDVNVEMDAAPGVDLSRILNEMRDQYEKMAEKNRKDAEEWFFTKTEELNREVATN
*******#* **************##**************** ******************#***#************
KEELAYLKKNHEEEMNALRGQVGGEINVEMDAAPGVDLSRILSEMRDQYEKMAEKNRKDAEDWFFSKTEELNREVATN
TEALQSSRTEITELRRSVQNLEIELQSQLSMKASLENSLAETEARYGAQLAQLQGLISSVEQQLCELRCDMERQNHEY
#* #** ##**#****# * **************** ****** **  ** *#**** *** **  ***#** ** **
SELVQSGKSEISELRRTMQALEIELQSQLSMKASLEGSLAETENRYCVQLSQIQGLIGSVEEQLAQLRCEMEQQNQEY
QVLLDVKTRLEQEIATYRRLLEGEDAHLATQYSSSLASQPSREGMVTSRQVRTIVEEVQDGKVVSSREQVHRSTH*
 #************************** ***       *     **#***************#******* #*
KILLDVKTRLEQEIATYRRLLEGEDAHL-TQYK---PKEP-----VTTRQVRTIVEEVQDGKVISSREQVHQTTR*
D
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Figure 1
Genomic mapping and cloning of mK17n. (A), Location of mK17n at the telomeric boundary within the cluster of type I keratin genes on mouse
chromosome 11. This information was obtained from the Mouse Genome Sequencing Consortium (www.ensembl.org). It is consistent with and
extends previous mapping studies for mouse type I genes (Filion et al, 1994; Sato et al, 1999). (B), RT-PCR analysis of the distribution of mK17n and
mK17 mRNA in various tissues from C57Bl/6 wild-type (wt) and mK17 null mice. Primers for b-tubulin are used as an internal reference. (1) wt back
skin, (2) mK17 null back skin, (3) wt tongue, (4) mK17 null tongue, (5) wt digits, (6) mK17 null digits, (7) wt vibrissae, (8) mK17 null vibrissae, (9) wt liver,
and (10) mK17 null liver. As shown, mK17n mRNA is detectable in tongue, digits, and vibrissae via RT-PCR analysis. (C), Structure of mK17n. Exons
1–8 are indicated by black boxes. Introns 1–7 are indicated by double lines between exons. (D), comparing the predicted amino acid sequences of
mK17n (GenBank Acc. No. AY459292) and mK17. Identical and conservative amino acids are marked with  and #, respectively. The underlined
sequence corresponds to the peptide used to generate the polyclonal antibody to K17.
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The C-terminus is highly conserved between the two
proteins, consistent with their shared immunoreactivity with
an antiserum generated against a K17 C-terminal peptide
(McGowan and Coulombe, 1998a).
Expression of mK17n is highly restricted and most
prominent in the nail bed We exploited in situ hybridiza-
tion to map the distribution of mK17n mRNA in the skin and
oral mucosa of adult wild-type mice, and compare it with
mK17 mRNA. Specific antisense and sense (control) probes
corresponding to exon 8 of these two genes were used. A
strong signal for the mK17n mRNA can be detected using
the antisense, but not the sense, probe in the nail matrix and
nail bed (Fig 2A and A0). By comparison, mK17 transcripts
occur in these compartments as well, and also in the
proximal nail fold (Fig 2B), as previously reported (Smith
et al, 1998; McGowan and Coulombe, 1998a, 2000; De Berker
et al, 2000). In striking contrast to mK17, however, mK17n
transcripts cannot de detected in pelage (Fig 2C and D) or
tail skin tissue (data not shown). In whisker pads, a faint
hybridization signal for mK17n reproducibly occurs in the
companion layer of vibrissae follicles (Fig 2E), whereas
the signal for mK17 is considerably stronger and includes
the outer root sheath, matrix, and medulla compartments
(Fig 2F). In the oral mucosa, finally, a weak signal with the
antisense probe to mK17n can be reproducibly detected in
both filiform and fungiform papillae (Fig 2G and G0). Again,
here, the hybridization signal for mK17 is much stronger and
broadly distributed in these structures (Fig 2H and H0). The
specificity of the signal for both mK17 and mK17n in the nail
bed was confirmed through the use of sense probes as
controls (see Fig 2A, inset and data not shown). Moreover,
identical results were obtained in two different inbred
mouse strains, 129SvJ (Fig 2C–F and data not shown)
and C57Bl/6 (Fig 2A, A0, B, G, G0, H, H0, and data not
shown). No hybridization was seen when using the mK17
antisense probe on sections prepared from mK17 null tissue
tissues, with the notable exception of the nail bed (data not
shown). At another level, we looked for the presence of
mK17n mRNA in a number of additional mouse tissues
(the salivary gland, esophagus, trachea, forestomach, anal
canal, bladder, and cervix) using RT-PCR, and found no
evidence of expression.
Amino acid conservation between mK17 and mK17n
within the C-terminal region is such (Fig 1D) that it appears
likely that our rabbit polyclonal antiserum, originally made
against a C-terminal peptide conserved in human and
mouse K17 (McGowan and Coulombe, 1998a), would
cross-react with mK17n. In support of this, transient
expression of the mK17n cDNA under the control of a
cytomegalovirus (CMV) promoter in PtK2 kidney epithelial
cells can be detected with this antiserum (Fig 3A). mK17n
immunofluorescence is restricted to transfected cells, and
occurs in a filamentous pattern that colocalizes with the
endogenous K8/K18 filament network (Fig 3B), also con-
firming that mK17n is a bona fide keratin filament-forming
protein. Next, we applied this antibody to tissue sections
prepared from mK17 null mice. As expected, a signal was
detected in the nail bed epithelium (Fig 3C), corroborating
the in situ hybridization findings. No immunostaining was
detected when applying this antiserum on sections pre-
pared from mK17 null backskin (Fig 3D).
Implications for epithelial alterations associated with
defects in K17 protein The lack of nail involvement in
mK17 null mice, a surprising occurrence, was left unsolved
in our original report (McGowan et al, 2002). This is in
contrast to hair follicles and sweat glands, in which specific
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Figure 2
Comparing mK17n and mK17 mRNA distribu-
tion in mouse tissues by in situ hybridization.
(A, A0, B, G, G0, H, H0) 12-d-old C57Bl/6 wild-
type mice tissues. (C–F) Tissues from 12–d-old
129SvJ mice. (A) Section through digits hybri-
dized with mK17n antisense probe. (A0) Serial
section to A hybridized with control sense probe
to mK17n. (B) Section through digits hybridized
with mK17 antisense probe. (C) Anagen-stage
back skin hybridized with mK17n antisense
probe. (D) Anagen-stage back skin hybridized
with mK17 antisense probe. (E) Section through
vibrissae hybridized with mK17n antisense
probe. (F) Section through vibrissae hybridized
with mK17 antisense probe. (G,G0) Dorsal tongue
epithelium hybridized with mK17n antisense
probe. (H,H0) Dorsal tongue epithelium hybridized
with mK17 antisense probe. Abbreviations are as
follows: bed, nail bed; cl, companion layer; np,
nail plate; mat, matrix; pnf, proximal nail fold; ors,
outer root sheath; med, medulla; dp, dermal
papillae; fil, filiform papillae; fung, fungiform
papillae. Bars¼ 50 mm.
968 TONG AND COULOMBE THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
keratins (K16 and K14, respectively) could be implicated in
a compensatory response. The discovery of a novel, K17-
related type I keratin gene, and the demonstration of its
preferred expression in the nail bed and matrix, provides a
likely explanation for the normalcy of the nail in mK17 null
mice. Possibly, mK17n could also contribute to the lack of
lesions in the oral mucosa of mK17 null mice, although it is
not expected to influence the hair phenotype.
Several years ago, Troyanovsky et al (1992) reported on
the existence of a type I gene located 50 upstream from the
functional K17 gene on human chromosome 17, but made
the determination that it was likely not functional. Yet, recent
database mining using exon 8 from this gene as a virtual
probe yielded several ESTs from a human testis cDNA
library (data not shown). Given the data reported here for
the corresponding locus in mouse, the status of this human
gene should be reexamined. Surveying the literature reveals
that there are cases of PC disease in which clinical
alterations are restricted to the nail (Chang et al, 1994;
Pryce and Verbov, 1994; Dogra et al, 2002). Inherited
defects in this hypothetical human gene could account for
this unusual form of PC disease. In the event that this
human locus is functional and regulated in a fashion similar
to mK17n, this could also account for the unusual
observation that all mutations discovered so far in human
K17 map to the 1A subdomain. Mutations in this particular
domain are usually associated with severe manifestations of
keratin-based diseases (Irvine and McLean, 1999). The
possibility that, at least in nail tissue, mK17n could trivialize
the consequences of missense mutations affecting other
regions of K17 protein is attractive, and warrants further
investigation.
Materials and Methods
Animals and antibodies All studies involving animals were
approved by the Institutional Animal Care and Use Committee at
the Johns Hopkins University School of Medicine. Wild-type
129SvJ and C57Bl/6 mice were purchased from Jackson Labora-
tories (Bar Harbor, Maine) and the National Cancer Institute
(Frederick, Maryland). Inbred mouse strains carrying an mK17 null
allele were described (McGowan et al, 2002). A rabbit polyclonal
antiserum, made against a conserved peptide at the C-terminus of
mouse and human K17 (NH2–CSSREQVHQTTR–COOH) was used
(McGowan and Coulombe, 1998a). A mouse monoclonal antibody
(L2A1) directed against K8/K18 was also used (Chou and Omary,
1993). Anti-Digoxigenin-AP Fab fragments were obtained from
Roche (Mannheim, Germany). Fluorochrome-conjugated goat
antirabbit and antimouse antibodies were obtained from KPL
(Kirkegaard and Perry Laboratories, Gaithersburg, Maryland).
cDNA and genomic cloning, and database searching We
completed the sequencing of the mouse genomic DNA insert
contained within the previously described phage clone 16-8,
isolated from a 129Sv mouse genomic library (McGowan and
Coulombe, 1998a; Bernot et al, 2002). Located  2 kb telomeric
to the previously characterized mK17 gene (McGowan and
Coulombe, 1998a) is a complete type I keratin gene, as reported
to be the case in the human genome (Troyanovsky et al, 1992). This
assignment was validated by database mining at the National
Center for Biotechnology Information (www.ncbi.nlm.nih.gov) and
the Mouse Genome Sequencing Consortium (www.ensembl.org)
websites. Details are provided under Results. After tentatively
assigning the 50 and 30 boundaries of the coding sequence of this
novel keratin gene in mouse, oligonucleotide primers were
designed to obtain a partial cDNA clone encompassing the entire
protein coding sequence of the corresponding mRNA (Table I).
BamHI restriction sites (underlined in Table I) were included at the
50 end of each primer to facilitate subcloning of the amplicons
(Table I). RT-PCR was performed as described (Paladini et al, 1995)
on total RNA prepared from 33-d-old C57Bl/6 mice. The following
conditions were applied during PCR: 4 min at 941C, followed by 30
cycles of 1 min at 941C (denaturation), 1 min at 621C (annealing),
and 1.5 min at 721C (elongation). b-tubulin (Table I) was used as an
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Figure 3
Expression of mK17n in transfected epithelial cells in culture and
mK17 null tissues. (A,B) Transient transfection of mK17n cDNA in PtK2
kidney epithelial cells. In ‘‘A’’ the transfected mK17n antigen is detected
with the mK17 rabbit polyclonal antiserum. In ‘‘B’’ the endogenous
keratin IF network of PtK2 cells (K8/K18) is immunostained with
monoclonal antibody L2A1. Bar¼ 10 mm. (C,D) Frozen sections of digits
and back skin from 33-d-old mK17 null mice (C57Bl/6 strain)
immunostained for K17n antigen. Positive signal is detected in the nail
bed (C), but not in back skin hair follicles (D). The positive signal
detected on the ventral side of the nail () corresponds to a sectioning
plane effect. Bars¼50 mm. Abbreviations are as follows: n, nucleus; np,
nail plate; bed, nail bed; med, medulla; ors, outer root sheath; bulb,
hair bulb.
Table I. List of oligonucleotide primers and relevant information
Product
Size
(kb) Forward primer (50–30 direction) Reverse primer (50–30 direction)
Annealing temperature
(1C)
mK17n cDNA  1.5 CTGGATCCTGAGGATACC CAATGGATCCAATTTCTG 62
ATGGATTCCACTACCAGTGTCC GGGTCAACCCAAGGGGCCTCTC
mK17 cDNA  1.4 TCCTCCAGCTCTATCAAGGGCTCC GGTCTCAAGCATAGGAATGCTGGGG 62
b-tubulin  0.4 CAACGTCAAGACGGCCGTGTG GACAGAGGCAAACTGAGCACC 62
mK17n in situ probe  0.3 CATGGTGACCAGCCGCCAGGTGC CAATTTCTGGGGTCAACCCAAGGGGC 62
mK17 in situ probe  0.3 CCACCTGACTCAGTACAAGCCAAAAG CAGTGTTCAGAACAAAGGCCACAG 62
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internal control in all RT-PCR assays. The  1.5 kb amplicon
obtained when using mK17n-specific primers was subcloned in the
pGEM-T Easy vector (Promega, Madison, Wisconsin), and se-
quenced. Further validation of the mK17n coding sequence was
carried out by comparison with entries available at the databases
mentioned above. The cDNA clone was used as a template to
analyze the virtual genomic clone described above. In-house
sequence analyses were performed using the DNAsis v3.5
software (Hitachi Software Engineering Co, Japan).
Morphological analyses Immunolocalization of protein antigens
(McGowan and Coulombe, 1998a) was carried out via a fluor-
ochrome-based detection method using sections prepared from
fresh frozen tissues embedded in OCT compound (Sakura Finetec,
Torrance, California). In situ hybridization (Mazzalupo and Cou-
lombe, 2001) was performed on frozen sections prepared from
paraformaldehyde-fixed, OCT-embedded tissues. Probes specific
for the mK17 and mK17n transcripts were obtained by PCR using
oligonucleotide primers complementary to exon 8 boundaries
(Table I). Digoxigenin-labeled sense (control) and antisense probes
corresponding to mK17 (287 bp) and mK17n (255 bp) were made
according to the MAXIscript protocol (Ambion Inc, Austin, Texas)
and hybridized to sections. After washes, bound probe was
revealed by alkaline phosphatase activity (Bio-Rad Labs, Rich-
mond, California). The templates for probe synthesis correspond to
the C-terminal tail domain and most of the 30 non-coding region in
each of mK17 and mK17n.
Transient transfection assays The mK17n cDNA was subcloned
in a cytomegalovirus promoter-containing plasmid vector for
mammalian expression (pBK-CMV; Stratagene, La Jolla, Califor-
nia). PtK2 cells, which originate from rat podoroo kidney epi-
thelium, were maintained in culture as described (American Tissue
Culture Collection, Rockville, Maryland). Transient transfection was
carried out using polyethylenimine (PEI) (Aldrich, Milwaukee,
Winconsin) as described (Boussif et al, 1995). Cells were methanol-
fixed at 48 h after transfection and processed for double-immuno-
fluorescence labeling (Wang et al, 2003).
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